This year, Conisus made charitable donations to the Leukemia & Lymphoma Society, Gilda’s Club New York City, and the Bonnie J. Addario Lung Cancer Foundation.

by Conisus
back to news

Atlanta, November 24, 2015 – Before every cancer diagnosis, there’s a human being. A family member. A loved one. A person—both before a diagnosis and every single day thereafter. The fight against cancer is always a fight on behalf of persons. This fight is personal. And we’re honored to support that fight both through our corporate mission and our charitable giving.

This year, Conisus made charitable donations to the Leukemia & Lymphoma Society, Gilda’s Club New York City, and the Bonnie J. Addario Lung Cancer Foundation, each of which are briefly described below.

The Leukemia & Lymphoma Society (LLS) is the tip of the spear for advances in blood cancer treatment. Describing itself as “a catalyst for collaboration,” LLS has a large number of active research projects, effective partnerships in Pharma and Biotech, and powerful patient advocacy. The LLS mission is simple—“to find cures and ensure access to treatments for blood cancer patients”—and their success is inspiring.

Gilda’s Club New York City (GCNYC) is a remarkable organization whose focus on individuals with cancer always includes the family and friends who fight alongside them. GCNYC was founded in 1995 by Gene Wilder, in loving memory of his wife Gilda Radner, the iconic Saturday Night Live comedienne lost to ovarian cancer in 1989. GCNYC offers comprehensive cancer support free of charge. Over the years, GCNYC has seen extraordinary success: “Since 1995, more than 11,000 individuals and families have visited our Clubhouse in the West Village in Manhattan or one of our off-site locations with hospital partners around New York City.”

Founded in 2006, the Bonnie J. Addario Lung Cancer Foundation (ALCF) is a world leader in lung cancer research, early detection, education, and treatment. One of the largest nonprofit organizations of its kind, ALCF has raised approximately $25 million for lung cancer research in its mission to “extend and enhance the lives of patients and families affected by lung cancer.” Since its founding, ALCF has remained “patient-founded, patient-focused, and patient-driven.”

Conisus
Founded in 1999 and based in Atlanta, Conisus is a leading provider of strategic medical communication services to the biopharmaceutical industry. We are dedicated to improving the care of patients with serious or life-threatening conditions by delivering superior medical education programs to healthcare professionals. Our goal is to provide best-in-class strategic services while demonstrating unrivaled service to healthcare professionals, clients, and educational supporters, ensuring that all operations reflect the highest degree of integrity.